Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03781102 · ClinicalTrials.gov registry record · NA
Type 2 Diabetes Prevention in Community Health Care Settings for at Risk Children and Mothers
A NA study, sponsored by University of Arizona.
- Terminated
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT03781102 is a NA study that was terminated before completion, run by University of Arizona. The registered enrollment target is 92 participants.
The verdict
NCT03781102, a NA study, was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
The two main questions that this research study will answer: 1. will a 16-week community-based diabetes prevention program for delivery to at-risk mothers and children in a Federally Qualified Health Center (FQHC) setting show (a) pre- and post-intervention improvements to Type 2 Diabetes risk factors in 60 mother-child dyads; (b) intervention vs. control improvements to T2D risk factors in 30 mother-child dyads; and (c) maintenance effects to changes to Type 2 Diabetes risk factors in 30 mother-child dyads; and 2. based on the acceptability, adoption, relevance to FQHC and participants, feasibility, fidelity, program costs, and factors influencing sustainability of this program, can it be disseminated nationwide to other FQHC's? The investigators hypothesize that participants (a) will show improvements following the intervention to T2D risk factors, (b) in the intervention will show significant improvements to T2D risk factors in versus the controls, and (c) will maintain the benefits beyond the 16-week intervention. The investigators also predict that this program will meet criteria to be disseminated nationwide to other FQHC's.
Interventions
- BEHAVIORAL 16-Week Diabetes Prevention Program for Mothers and Children
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2020-03-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03781102
The ClinicalTrials.gov registry entry for NCT03781102 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 16-Week Diabetes Prevention Program for Mothers and Children is the first listed.
NCT03781102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03781102 about?
NCT03781102 is a clinical study titled "Type 2 Diabetes Prevention in Community Health Care Settings for at Risk Children and Mothers". The two main questions that this research study will answer: 1. will a 16-week community-based diabetes prevention program for delivery to at-risk mothers and children in a Federally Qualified Health Center (FQHC) setting show (a) pre- and post-intervention improvements to Type 2 Diabetes risk fact...
What is the current status of trial NCT03781102?
This trial is currently terminated. It is a NA study. The enrollment target is 92 participants. The study started on 2019-07-01. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT03781102?
The interventions under investigation include: 16-Week Diabetes Prevention Program for Mothers and Children (BEHAVIORAL).
Who is sponsoring clinical trial NCT03781102?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.